GMP ActiveMax® Streptavidin μBeads

Customer Reviews
Cat. No. / Size
Price
Qty
GMP-MBS009-10mg
$1200.00
GMP-MBS009-100mg (10mg X 10)
$7350.00
GMP-MBS009-1000mg (10mg X 100)
$63000.00
ETA of in-stock products:2 business days

Product Details

  • Product Show

    Streptavidin PRODUCT SHOW

    This product can be directly isolated using conventional column-free magnetic stand (eg. Cat. MB-01/ MB-02/ MB-03/ MB-04). Please note that due to its micron-scale size, it is not compatible with commercially available column-based (M/D/L) magnetic separation systems.

  • Features

    1. Core Technical Advantages
      1. No separation columns required, magnetic stand enables fast post-culture bead-cell separation
      2. No internalization risk, 5.5μm beads resist cellular uptake, protecting cell metabolism and function
      3. Directly conjugate to biotinylated antibodies/proteins for cell sorting, activation, and expansion
      4. Premium Grade (Pre-GMP) and GMP versions offer identical performance for seamless R&D to manufacturing transition
    2. Compliance & Manufacturing Assurance
      1. Designed under ISO 9001:2015 and ISO 13485:2016
      2. Manufactured and QC tested under a GMP-compliant factory
      3. Stringent quality control tests
    3. Material & Quality Attributes
      1. Animal-Free materials
      2. Beta-lactam materials free
      3. Batch-to-batch consistency
      4. GMP-grade recombinant HSA as an excipient
  • Product Description

    GMP ActiveMax® Streptavidin μBeads are uniform, superparamagnetic beads of 5.5 µm with streptavidin on their surface. Streptavidin is a tetrameric protein that provides four high-affinity biotin binding sites, making it possible to quickly prepare and customize your own sterile protein/antibody-coupled beads for cell-based assays, cell sorting, cell therapy process development, and manufacturing use.
    GMP ActiveMax® Streptavidin μBeads are manufactured under a GMP-compliant factory with animal-free raw materials and tested under GMP guidelines.

  • Application

    GMP ActiveMax® Streptavidin μBeads can be used for coupling of any biotinylated proteins or antibodies, and are ideal for numerous applications as follows:
    When coupled with biotinylated CAR target proteins, it can be used to stimulate or isolate CAR-T cells or UCAR-T cells.
    When coupled with biotinylated antibodies, it can be used to isolate antigen-specific cells, including immune cells and tumor cells, etc.
    When coupled with biotinylated drug targets, it can be used for screening target specific antibodies by FACS.
    It can also be used for other cell-based experiments that you need.

  • Storage

    This product is stable after storage at -70℃ for 2 years.

  • Sterility

    Sterility testing was performed using the membrane filtration method in compliance with USP <71> and Ph. Eur. 2.6.1.

  • Endotoxin

    Less than 2 EU per mL, tested by the rFC method in compliance with USP <86> and Ph. Eur. 2.6.32.

  • Mycoplasma

    Negative

  • Formulation

    GMP ActiveMax® Streptavidin μbeads is supplied with 5x10⁷ beads/mL in PBS, pH 7.4, with 0.1% recombinant human serum albumin (recombinant HSA), and trehalose is added as protectant.

  • Vial Specification

    6R (20 mm neck finish)

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • FACS Data

     Streptavidin FACS

    GMP ActiveMax Streptavidin μBeads coupled with protein 4 ug of the Biotinylated Human BCMA, His,Avitag, premium grade (Cat. No. BCA-H82E4) was added to 0.1 mg of GMP ActiveMax® Streptavidin μBeads (Cat. No. GMP-MBS009), mixed well and incubated for 60 minutes at room temperature. And then the coupled μbeads were fluorescently stained using PE labeled anti-human BCMA antibody and analyzed by flow cytometry (QC tested).

    Protocol
  •  Streptavidin FACS

    GMP ActiveMax Streptavidin μBeads coupled with protein. 50ug of the biotinylated human CD19 protein (Cat. No. CD9-H82E9) was added to 1mg of GMP ActiveMax® Streptavidin μBeads (Cat. No. GMP-MBS009), mix well and incubate for 60 minutes at room temperature. And then the coupled μbeads were fluorescently stained using PE labeled anti-human CD19 antibody and analyzed by flow cytometry (Routinely tested).

    Protocol
  • Stability

     Streptavidin STABILITY

    FACS assay demonstrates that GMP ActiveMax® Streptavidin μBeads (Cat. No. GMP-MBS009) is stable at 37°C for 14 hours.

  •  Streptavidin STABILITY

    FACS assay demonstrates that GMP ActiveMax® Streptavidin μBeads (Cat. No. GMP-MBS009) is stable after 3 freeze-thaw cycles.

  •  Streptavidin STABILITY

    FACS assay demonstrates that GMP ActiveMax® Streptavidin μBeads (Cat. No. GMP-MBS009) is stable at 4°C for 180 days.

Customer Reviews
Writing Reviews

Important Statement

  • MANUFACTURING SPECIFICATIONS

    ACROBiosystems GMP grade products are produced under a quality management system and in compliance with relevant guidelines: Ph. Eur General Chapter 5.2.12 Raw materials of biological origin for the production of cell-based and gene therapy medicinal products; USP<92>Growth Factors and Cytokines Used in Cell Therapy Manufacturing; USP<1043>Ancillary Materials for Cell, Gene, and Tissue-Engineered Products; ISO/TS 20399-1:2018, Biotechnology - Ancillary Materials Present During the Production of Cellular Therapeutic Products.

    ACROBiosystems Quality Management System Contents:

    1. GMP-certified facility (compliance with FDA cGMP, EMA GMP, ICH, ISO9001/13485/MDSAP, and certified by third-party SGS, UL, and RX360)
    2. Animal origin-free materials, equipments, and facilities
    3. Materials sourced only from approved suppliers
    4. ISO 5 cleanrooms and automatic filling equipment
    5. Professional quality personnel and training programs
    6. Validated analytical testing methods in accordance with the ICH guidelines
    7. Safety Testing (Sterility, Mycoplasma, etc): compliant with USP, EP, etc
    8. In-depth stability studies
    9. Fully batch production and control records
    10. Equipment maintenance and calibration

    Request For Regulatory Support Files (RSF)

    ACROBiosystems provide rigorous quality control tests (fully validated equipment, processes and test methods) on our GMP grade products to ensure that they meet stringent standards in terms of purity, safety, activity and inter-batch stability, and each bulk QC lot mainly contains the following specific information:

    1. SDS-PAGE
    2. Protein content
    3. Endotoxin level
    4. Residual Host Cell DNA content
    5. Residual Host Cell Protein content
    6. Biological activity analysis
    7. Microbial testing
    8. Mycoplasma testing
    9. In vitro virus assay
    10. Batch-to-batch consistency

  • ACROBIOSYSTEMS - LEGAL NOTICES FOR GMP GRADE PRODUCTS

    1. PRODUCT USE RESTRICTIONS & PROHIBITIONS

    • 1.1 ACROBiosystems ("ACRO") GMP grade products ("Products") are designed for research, manufacturing use or ex vivo use.
    • 1.2 Products are NOT intended for diagnostic purposes or for direct or indirect administration into humans.
    • 1.3 Purchaser shall not market, distribute, or resell Products obtained from ACRO without ACRO's prior written consent.

    2. REVERSE ENGINEERING PROHIBITED & CONFIDENTIALITY

    • 2.1 Purchaser shall not reverse-engineer, decompile, disassemble, sequence, analyze via bioinformatics, or otherwise attempt to discover the structure, sequence, composition, construction, manufacturing process, or any trade secret embodied in the Products. Purchaser shall not permit any third party to undertake such activities.
    • 2.2 All specifications, data, and know-how related to the Products provided by ACRO are ACRO's confidential information and shall be protected accordingly.

    3. LIMITED WARRANTY & DISCLAIMERS

    • 3.1 ACRO warrants solely that Products will conform to their published specifications when used under normal, specified laboratory/manufacturing conditions and within their labeled expiration date. THIS IS THE ONLY WARRANTY PROVIDED.
    • 3.2 Purchaser assumes ALL risk and responsibility for:
      (a) Determining the suitability of Products for Purchaser's intended application(s).
      (b) Obtaining any necessary regulatory approvals or intellectual property licenses for Purchaser's use.
      (c) Compliance with all applicable laws, regulations (including but not limited to cGMP/GLP where claimed), and industry standards.
      (d) Conducting all necessary quality control, safety, efficacy, and validation testing of Products within Purchaser's process or final product.
      (e) Proper storage, handling, and use of Products according to ACRO's instructions.
    • 3.3 ACRO EXPRESSLY DISCLAIMS ALL OTHER WARRANTIES, WHETHER EXPRESS, IMPLIED, STATUTORY, OR OTHERWISE, INCLUDING BUT NOT LIMITED TO: (A) WARRANTIES OF MERCHANTABILITY; (B) WARRANTIES OF FITNESS FOR A PARTICULAR PURPOSE; (C) WARRANTIES OF NON-INFRINGEMENT; AND (D) WARRANTIES ARISING FROM COURSE OF DEALING OR USAGE OF TRADE.

    4. LIMITATION OF LIABILITY

    • IN NO EVENT SHALL ACRO, ITS AFFILIATES, OR SUPPLIERS BE LIABLE FOR ANY OF THE FOLLOWING, HOWSOEVER ARISING (WHETHER IN CONTRACT, TORT (INCLUDING NEGLIGENCE), STRICT LIABILITY, STATUTE, OR OTHERWISE):
      (a) LOST PROFITS, LOST REVENUE, LOST SAVINGS, LOSS OF USE, LOSS OF DATA, BUSINESS INTERRUPTION, OR ANY OTHER INDIRECT, INCIDENTAL, SPECIAL, PUNITIVE, OR CONSEQUENTIAL DAMAGES.
      (b) ANY DIRECT DAMAGES, COSTS, OR EXPENSES EXCEEDING THE AMOUNT PAID BY PURCHASER FOR THE SPECIFIC PRODUCT(S) GIVING RISE TO THE CLAIM.
      (c) DAMAGES ARISING FROM: (i) MISUSE, ABUSE, OR UNAUTHORIZED MODIFICATION OF PRODUCTS; (ii) USE BEYOND THE EXPIRATION DATE; (iii) IMPROPER STORAGE OR HANDLING; (iv) ACCIDENTAL DAMAGE; (v) FAILURE TO CONDUCT ADEQUATE VALIDATION OR TESTING BY PURCHASER; (vi) INFRINGEMENT CLAIMS RELATED TO PURCHASER'S USE; OR (vii) THE COST OF PROCURING SUBSTITUTE GOODS OR SERVICES.
      (d) ANY PERSONAL INJURY, DEATH, OR DAMAGE TO TANGIBLE PROPERTY TO THE EXTENT PERMITTED BY LAW.

    5. END USER ACKNOWLEDGEMENT & COMPLIANCE

    • 5.1 By accepting, opening, or using the Products, the End User (Purchaser or its downstream recipient) agrees to be irrevocably bound by all terms herein.
    • 5.2 End User explicitly acknowledges the Products are NOT FOR HUMAN ADMINISTRATION and agrees not to use them in any in vivo human application, directly or indirectly.
    • 5.3 End Users unwilling to accept these terms must immediately: (a) cease all use; (b) notify ACRO or their supplier; and (c) return the unopened, unused Products.
    • 5.4 ACRO reserves the right to audit End User's compliance with these restrictions upon reasonable notice.

    ACRO has the right, at its sole discretion, to modify, add or remove any terms herein without notice to Purchaser and/or End User. Any changes to these terms are effective immediately following the updating of such changes on ACRO’s website or published specifications or product-related documents.

Recent Advances

 
Contact Us
Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Important Statement
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland